These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16889095)

  • 1. [Tuberculosis of the urinary bladder: diagnosis and treatment].
    Kul'chavenia EV; Brizhatiuk EV
    Urologiia; 2006; (3):61-4, 66. PubMed ID: 16889095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical trial to evaluate trospium chloride (Uraplex) effectiveness and tolerance in patients with detrusor instability incontinence and its impact on quality of life].
    Fuertes ME; García Matres MJ; González Romojaro V; de la Rosa S; Anguera Vila A; de la Peña J; Leiva Galvis O; Sánchez Chapado M
    Arch Esp Urol; 2000 Mar; 53(2):125-36. PubMed ID: 10802918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter phase III trial studying trospium chloride in patients with overactive bladder.
    Rudy D; Cline K; Harris R; Goldberg K; Dmochowski R
    Urology; 2006 Feb; 67(2):275-80. PubMed ID: 16461077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder.
    Zinner N; Harnett M; Sabounjian L; Sandage B; Dmochowski R; Staskin D
    J Urol; 2005 May; 173(5):1639-43. PubMed ID: 15821526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Palérol in the treatment of bladder tuberculosis].
    Krakowski J
    Ther Umsch; 1968 May; 25(5):293-4. PubMed ID: 5751560
    [No Abstract]   [Full Text] [Related]  

  • 8. Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release.
    Chancellor MB; Oefelein MG; Vasavada S
    Neurourol Urodyn; 2010 Apr; 29(4):551-4. PubMed ID: 19634167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urogenital tuberculosis. Apropos of 40 cases].
    el Khader K; el Fassi J; Karmouni T; Tazi K; Ibnattya A; Hachimi M; Lakrissa A
    Ann Urol (Paris); 1997; 31(6-7):339-43. PubMed ID: 9509233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravaginal electrical stimulation and trospium hydrochloride in women with overactive bladder syndrome: a randomized controlled study.
    Ozdedeli S; Karapolat H; Akkoc Y
    Clin Rehabil; 2010 Apr; 24(4):342-51. PubMed ID: 20212061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials.
    Ginsberg DA; Oefelein MG; Ellsworth PI
    Neurourol Urodyn; 2011 Apr; 30(4):563-7. PubMed ID: 21268101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trospium chloride (Sanctura)--new to the U.S. for overactive bladder.
    Gaines KK
    Urol Nurs; 2005 Feb; 25(1):64-5, 52. PubMed ID: 15779697
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trospium chloride in the treatment of idiopathic and neurogenic detrusor overactivity].
    Mazo EB; Krivoborodov GG; Shkol'nikov ME; Babanina GA; Kozyrev SV; Korshunov ES
    Urologiia; 2005; (4):56-9. PubMed ID: 16158750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of urinary bladder dysfunctions in patients with nephrotuberculosis].
    Zuban' ON; Iagafarova RK; Vinogradova TI
    Urologiia; 2006; (5):37-40, 45. PubMed ID: 17444151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trospium chloride (Sanctura): another anticholinergic for overactive bladder.
    Med Lett Drugs Ther; 2004 Aug; 46(1188):63-4. PubMed ID: 15289745
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous bladder perforation: a rare complication of tuberculosis.
    Kong CH; Ali SA; Singam P; Hong GE; Cheok LB; Zainuddin ZM
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e250-2. PubMed ID: 20117032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release.
    Staskin DR; Cardozo L
    Int J Clin Pract; 2009 Jun; 63(6):973-6. PubMed ID: 19459997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Palerol in the treatment of tuberculous cystitis].
    Krakowski J
    Przegl Lek; 1969; 25(3):320-2. PubMed ID: 5815365
    [No Abstract]   [Full Text] [Related]  

  • 19. Overactive bladder.
    Thacker HL; Paraiso M
    Cleve Clin J Med; 2005 Jul; 72(7):544; author reply 544-5. PubMed ID: 16044651
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trospium chloride (spasmex) in the treatment of lower urinary tract symptoms in patients with neurogenic hyperactive urinary bladder caused by vertebrogenic lesions].
    Mazo EB; Babanina GA
    Urologiia; 2007; (3):15-9. PubMed ID: 17722614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.